Adenoassociated virus vectors for the treatment of lysosomal storage disorders
US11149285B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 13, 2015 |
| Grant date | Oct 19, 2021 |
| Priority date | — |
| Expiry date | May 21, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/105
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides new adenoassociated virus vectors and pharmaceutical compositions containing the same for the treatment of lysosomal storage disorders and specially, for the treatment of mucopolysaccharidoses Type IIIB.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.